Given that RASSF1A is a master regulator of the Hippo pathway and that LATS kinases are implicated in the suppression of breast cancer, we hypothesized that RASSF1A and LATS kinases might cooperate to regulate ERα activity and suppress luminal breast cancer initiation and progression. Here, ESR1 is linked to breast carcinoma.